News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Davis Blaine
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/30/2022 |
4
| Davis Blaine (CFO) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 1,250,000 options to buy
@ $1.27, valued at
$1.6M
|
|
| 11/30/2022 |
3
| Davis Blaine (CFO) has filed a Form 3 on SELECTA BIOSCIENCES INC |
| 07/19/2022 |
4
| Davis Blaine (CFO) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 5,081 shares
@ $3.13, valued at
$15.9k
|
|
| 01/05/2022 |
4
| Davis Blaine (CFO) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Granted 14,100 shares
@ $0
Granted 84,800 options to buy
@ $6.9, valued at
$585.1k
|
|
| 01/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2020 |
4
| Davis Blaine (CFO) has filed a Form 4 on Protara Therapeutics, Inc.|
Txns:
| Bought 1,481 shares
@ $16.906, valued at
$25k
|
|
| 02/11/2020 |
4
| Davis Blaine (CFO) has filed a Form 4 on ArTara Therapeutics, Inc.|
Txns:
| Granted 94,000 options to buy
@ $37.3, valued at
$3.5M
|
|
| 02/11/2020 |
3
| Davis Blaine (CFO) has filed a Form 3 on ArTara Therapeutics, Inc. |
|
|